Laidlaw Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,843
| Closed | -$386K | – | 200 |
|
|
2023
Q4 | $386K | Sell |
2,843
-58
| -2% | -$7.88K | 0.14% | 153 |
|
|
2023
Q3 | $355K | Buy |
2,901
+166
| +6% | +$20.3K | 0.12% | 185 |
|
|
2023
Q2 | $347K | Sell |
2,735
-386
| -12% | -$49K | 0.07% | 242 |
|
|
2023
Q1 | $403K | Sell |
3,121
-148
| -5% | -$19.1K | 0.08% | 226 |
|
|
2022
Q4 | $429K | Sell |
3,269
-44
| -1% | -$5.78K | 0.09% | 213 |
|
|
2022
Q3 | $387K | Sell |
3,313
-451
| -12% | -$52.7K | 0.09% | 205 |
|
|
2022
Q2 | $443K | Sell |
3,764
-163
| -4% | -$19.2K | 0.09% | 210 |
|
|
2022
Q1 | $512K | Sell |
3,927
-486
| -11% | -$63.4K | 0.09% | 215 |
|
|
2021
Q4 | $674K | Buy |
+4,413
| New | +$674K | 0.11% | 188 |
|
|
2021
Q1 | – | Sell |
-6,120
| Closed | -$927K | – | 278 |
|
|
2020
Q4 | $927K | Buy |
6,120
+340
| +6% | +$51.5K | 0.2% | 131 |
|
|
2020
Q3 | $783K | Sell |
5,780
-282
| -5% | -$38.2K | 0.35% | 80 |
|
|
2020
Q2 | $829K | Buy |
6,062
+438
| +8% | +$59.9K | 0.43% | 70 |
|
|
2020
Q1 | $606K | Sell |
5,624
-153
| -3% | -$16.5K | 0.4% | 75 |
|
|
2019
Q4 | $696K | Buy |
+5,777
| New | +$696K | 0.44% | 77 |
|